• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测阿尔茨海默病相关生物标志物的可逆免疫红外传感器。

Reversible Immuno-Infrared Sensor for the Detection of Alzheimer's Disease Related Biomarkers.

机构信息

Department of Biophysics , Ruhr-Universität Bochum , Universitätsstrasse 150 , D-44801 Bochum , Germany.

Center for Protein Diagnostics (ProDi) , Gesundheitscampus 4 , 44801 Bochum , Germany.

出版信息

ACS Sens. 2019 Jul 26;4(7):1851-1856. doi: 10.1021/acssensors.9b00631. Epub 2019 Jul 10.

DOI:10.1021/acssensors.9b00631
PMID:31241315
Abstract

The development of biosensors for medical purposes is a growing field. An immuno-infrared biosensor for the preclinical detection of Alzheimer's disease (AD) in body fluids was developed. The key element of this sensor is an ATR crystal with chemically modified surface to catch the biomarker out of the body fluid. So far, the immuno-infrared sensor can be used only once and requires time-consuming steps of sensor exchange, sensor cleaning, and novel surface functionalization. Here, we developed an immuno-infrared sensor providing a reusable surface and showcase its performance by the detection of the AD biomarker proteins Aβ and Tau in human cerebrospinal fluid (CSF). The sensor surface is covalently coated with the immunoglobulin binding proteins Protein A or Protein G. These were employed for noncovalent immobilization of antibodies and the subsequent immobilization and analysis of their antigens. The reversible antibody immobilization can be repeated several times with the same or different antibodies. Further, the more specific binding of the antibody via its Fc region instead of the conventional NHS coupling leads to a 3-4-fold higher antigen binding capacity of the antibody. Thus, the throughput, sensitivity, and automation capacity of the immuno-infrared biosensor are significantly increased as compared to former immuno-infrared assays. This immuno-sensor can be used with any antibody that binds to Protein A or Protein G.

摘要

用于医疗目的的生物传感器的发展是一个不断增长的领域。已经开发出用于在体液中临床前检测阿尔茨海默病(AD)的免疫-红外生物传感器。该传感器的关键元件是具有化学修饰表面的 ATR 晶体,用于从体液中捕获生物标志物。到目前为止,免疫-红外传感器只能使用一次,并且需要耗时的传感器更换、传感器清洁和新的表面功能化步骤。在这里,我们开发了一种免疫-红外传感器,提供了可重复使用的表面,并通过检测人脑脊液(CSF)中的 AD 生物标志物蛋白 Aβ和 Tau 展示了其性能。传感器表面通过共价涂层与免疫球蛋白结合蛋白 Protein A 或 Protein G 结合。这些用于非共价固定化抗体,随后固定化并分析其抗原。相同或不同的抗体可以重复进行可重复的抗体固定化。此外,抗体通过其 Fc 区域的更特异性结合而不是传统的 NHS 偶联导致抗体的抗原结合能力提高了 3-4 倍。因此,与以前的免疫-红外测定相比,免疫-红外生物传感器的通量、灵敏度和自动化能力显著提高。这种免疫传感器可以与任何结合蛋白 A 或蛋白 G 的抗体一起使用。

相似文献

1
Reversible Immuno-Infrared Sensor for the Detection of Alzheimer's Disease Related Biomarkers.用于检测阿尔茨海默病相关生物标志物的可逆免疫红外传感器。
ACS Sens. 2019 Jul 26;4(7):1851-1856. doi: 10.1021/acssensors.9b00631. Epub 2019 Jul 10.
2
Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.采用基于微球的 xMAP 多重分析技术同步分析脑脊液生物标志物,用于阿尔茨海默病的早期检测。
Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Epub 2012 Apr 6.
3
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
4
Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.阿尔茨海默病脑脊液的蛋白质组学分析:死活不论
J Alzheimers Dis. 2015;44(4):1303-12. doi: 10.3233/JAD-140141.
5
Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ and T-Tau assays for Alzheimer's disease diagnosis.用于阿尔茨海默病诊断的自动 Lumipulse 脑脊液 Aβ 和 T-Tau 分析及临床性能。
J Neurol. 2019 Sep;266(9):2304-2311. doi: 10.1007/s00415-019-09418-6. Epub 2019 Jun 10.
6
The role of cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis. where are we now?脑脊液生物标志物在阿尔茨海默病诊断中的作用。我们目前处于什么阶段?
Recent Pat CNS Drug Discov. 2013 Apr;8(1):70-8. doi: 10.2174/1574889811308010006.
7
A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease.一种用于诊断阿尔茨海默病的脑脊液生物标志物
Braz J Psychiatry. 2019 Nov-Dec;41(6):467-468. doi: 10.1590/1516-4446-2019-0629.
8
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.阿尔茨海默病标准化脑脊液生物标志物在澳大利亚成像、生物标志物和生活方式(AIBL)研究中经PET淀粉样β蛋白特征化的受试者中得到验证。
J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247.
9
Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.在常规实践中,将β淀粉样蛋白42(Aβ₄₂)/β淀粉样蛋白40(Aβ₄₀)比值与脑脊液生物标志物磷酸化tau蛋白(P-tau)和Aβ₄₂一起使用,可提高阿尔茨海默病病理生理过程的证据水平。
J Alzheimers Dis. 2014;41(2):377-86. doi: 10.3233/JAD-131838.
10
Cerebrospinal fluid biomarkers for Alzheimer's disease: current limitations and recent developments.用于阿尔茨海默病的脑脊液生物标志物:当前局限性与近期进展
Curr Opin Psychiatry. 2015 Sep;28(5):402-9. doi: 10.1097/YCO.0000000000000179.

引用本文的文献

1
Aptamers as Diagnostic and Therapeutic Agents for Aging and Age-Related Diseases.适配体作为衰老及衰老相关疾病的诊断和治疗剂
Biosensors (Basel). 2025 Apr 5;15(4):232. doi: 10.3390/bios15040232.
2
Oriented Surface Immobilization of Antibodies Using Enzyme-Mediated Site-Specific Biotinylation for Enhanced Antigen-Binding Capacity.利用酶介导的位点特异性生物素化进行抗体的定向表面固定以增强抗原结合能力
Langmuir. 2025 Apr 29;41(16):10576-10585. doi: 10.1021/acs.langmuir.5c00656. Epub 2025 Apr 20.
3
Electrochemical Analysis of Amyloid Plaques and ApoE4 with Chitosan-Coated Gold Nanostars for Alzheimer's Detection.
壳聚糖包覆的金纳米星用于阿尔茨海默病检测的淀粉样斑块和载脂蛋白 E4 的电化学分析。
Biosensors (Basel). 2024 Oct 17;14(10):510. doi: 10.3390/bios14100510.
4
Artificial intelligence-coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases.人工智能耦合等离子体红外传感器用于检测神经退行性疾病中的结构蛋白生物标志物。
Sci Adv. 2023 Jul 14;9(28):eadg9644. doi: 10.1126/sciadv.adg9644. Epub 2023 Jul 12.
5
ATR-FTIR Biosensors for Antibody Detection and Analysis.ATR-FTIR 生物传感器在抗体检测和分析中的应用。
Int J Mol Sci. 2022 Oct 7;23(19):11895. doi: 10.3390/ijms231911895.
6
Recent Advancements in Biosensing Approaches for Screening and Diagnostic Applications.用于筛查和诊断应用的生物传感方法的最新进展
Curr Opin Biomed Eng. 2021 Sep;19. doi: 10.1016/j.cobme.2021.100318. Epub 2021 Jun 29.
7
Detection of the Chilli Leaf Curl Virus Using an Attenuated Total Reflection-Mediated Localized Surface-Plasmon-Resonance-Based Optical Platform.使用基于衰减全反射介导的局域表面等离子体共振的光学平台检测辣椒卷叶病毒
ACS Omega. 2021 Jun 29;6(27):17413-17423. doi: 10.1021/acsomega.1c01702. eCollection 2021 Jul 13.
8
Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer's disease.遗传易感性、血浆中的 Aβ 错误折叠与阿尔茨海默病。
Transl Psychiatry. 2021 May 1;11(1):261. doi: 10.1038/s41398-021-01380-0.
9
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.淀粉样蛋白-β错误折叠作为一种血浆生物标志物,可提示有主观认知下降的个体未来发生临床阿尔茨海默病的风险。
Alzheimers Res Ther. 2020 Dec 24;12(1):169. doi: 10.1186/s13195-020-00738-8.
10
ATR-FTIR spectroscopy and spectroscopic imaging for the analysis of biopharmaceuticals.用于生物制药分析的衰减全反射傅里叶变换红外光谱法和光谱成像技术
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Nov 5;241:118636. doi: 10.1016/j.saa.2020.118636. Epub 2020 Jun 22.